Option Care Health (NASDAQ:OPCH) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Option Care Health (NASDAQ:OPCH) announced its earnings results on Wednesday. The company reported $0.35 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $0.02, Zacks reports. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%.

Option Care Health Trading Up 1.5 %

Shares of OPCH stock traded up $0.51 on Wednesday, hitting $33.14. The stock had a trading volume of 1,459,994 shares, compared to its average volume of 1,734,869. The company’s 50 day moving average price is $28.07 and its 200-day moving average price is $28.00. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm has a market capitalization of $5.64 billion, a P/E ratio of 27.89, a P/E/G ratio of 2.30 and a beta of 1.35. Option Care Health has a 1 year low of $21.39 and a 1 year high of $34.17.

Wall Street Analyst Weigh In

OPCH has been the topic of several research analyst reports. JPMorgan Chase & Co. boosted their target price on Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Truist Financial cut their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and boosted their price target for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Finally, JMP Securities restated a “market outperform” rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $32.25.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.